KRX •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 06/08/2026 15:30
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeKRX
Market Capitalization5,786,743 mln
Float61.70 mln
Earnings Date08/01/2025
EPS
2,843
Exceptional
P / E
25.40
Elevated
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.24
Borderline
1-Year Forecast
134,100
Transformational upside
Relative Strength
46
/ 100
Slightly lagging
Business Description
Founded nearly a century ago, Yuhan Corporation is a South Korean pharmaceutical company with a global reach. The company produces and supplies a wide range of active drug ingredients and chemical compounds used in treatments for conditions such as infections, heart disease, diabetes, and HIV. Yuhan also supports other businesses by developing manufacturing processes, producing materials at various scales, and providing laboratory and regulatory guidance.